Invasive breast cancer molecular classification and the choice of adjuvant chemotherapy regimens        CHEN Jia-jian, LIU Guang-yu. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Corresponding author: LIU Guang-yu, E-mail: liugy123@yahoo.com
Abstract    With the adoption and development of gene expression technique, the heterogeneity at the molecular level of the breast cancer has attracted attention gradually. The different breast cancer subtypes have different epidemiological risk factors, different natural histories and different responses to systemic and local therapies. To identify the exact subtype of the breast cancer has profound significance on making individualized therapies. The consensus of St. Gallen Breast Cancer Conference 2011 has provided different treatment suggestions according to different subtypes, which indicates that the management of breast cancer has entered the age of advocating individualized treatment on the basis of the standardization multi-disciplinary treatment gradually.